Cargando…

Glioblastoma Immune Landscape and the Potential of New Immunotherapies

Glioblastoma (GBM) are the most common tumors of the central nervous system and among the deadliest cancers in adults. GBM overall survival has not improved over the last decade despite optimization of therapeutic standard-of-care. While immune checkpoint inhibitors (ICI) have revolutionized cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Daubon, Thomas, Hemadou, Audrey, Romero Garmendia, Irati, Saleh, Maya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591769/
https://www.ncbi.nlm.nih.gov/pubmed/33154756
http://dx.doi.org/10.3389/fimmu.2020.585616

Ejemplares similares